Thomas a. Fitzgerald Reports 5.5% Stake in Transcode Therapeutics as of June 14- SEC Filing
Thomas A. Fitzgerald報告SEC文件,在6月14日持有Transcode Therapeutics的5.5%股份。
Thomas a. Fitzgerald Reports 5.5% Stake in Transcode Therapeutics as of June 14- SEC Filing
Thomas A. Fitzgerald報告SEC文件,在6月14日持有Transcode Therapeutics的5.5%股份。
譯文內容由第三人軟體翻譯。